Skip to main content
PolicySpeak
← All files
FA

Federchimica - Assobiotec

Industry association · Italy

3
positions filed
in the 655 files tracked
2
legislative files
of 655 tracked
3
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 655 consultation files tracked so far (56,999 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Track Federchimica in PolicySpeak: request access →

Work at Federchimica - Assobiotec? so we know who speaks for it.

Follow the files Federchimica - Assobiotec engages with

One email on Tuesdays when a new position is filed on these 2 files, from Federchimica - Assobiotec or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Federchimica - Assobiotec filed 3 positions between 9 Jun 2026 and 28 Sept 2026, across 2 of the 655 legislative files tracked here, attaching a full position paper 3 times.

What they argued

Biotech Act IIfiled 9 Jun 2026PDFsource

Federchimica Assobiotec welcomes the Commission’s recommendation on the Biotech Act II as a strategic tool to strengthen the EU’s industrial competitiveness, support the transition to sustainable production models and promote the circular bioeconomy.

Filed in Italian · English published by the European Commission

Plants obtained by new genomic techniques: information requirements and verification of category 1 statusfiled 28 Sept 2026PDFsource

Assobiotec, the National Association for the Development of Biotechnology, considers the implementing act on Category 2 NGT plants to be a crucial element in ensuring that the new European regulatory framework is able to combine high safety standards with the ability to support innovation, competitiveness and sustainability of the European agri-food system.

Filed in Italian · English published by the European Commission

Plants obtained by new genomic techniques: information requirements and verification of category 1 statusfiled 28 Sept 2026PDFsource

Assobiotec, the National Association for the Development of Biotechnology, welcomes the launch of the consultation on the delegated act provided for in Regulation (EU) 2026/1388 on New Genomic Techniques (NGTs) as a key step to ensure a consistent and harmonised implementation of the new European regulatory framework.

Filed in Italian · English published by the European Commission

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Federchimica - Assobiotec next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.

Showing 5 of 27.

Is this your organization?

Everything on this page comes from Federchimica - Assobiotec’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.